eclipse proton therapy treatment planning system version 8.9 (Varian Medical)
90
Structured Review
Varian Medical
eclipse proton therapy treatment planning system version 8.9
Eclipse Proton Therapy Treatment Planning System Version 8.9, supplied by Varian Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eclipse+proton+therapy+treatment+planning+system+version+8%2E9/eclipse+proton+therapy+treatment+planning+system+version+8+9/pm32361662-66-4-12
Average 90 stars, based on 1 article reviews
Eclipse Proton Therapy Treatment Planning System Version 8.9, supplied by Varian Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eclipse+proton+therapy+treatment+planning+system+version+8%2E9/eclipse+proton+therapy+treatment+planning+system+version+8+9/pm32361662-66-4-12
Average 90 stars, based on 1 article reviews
eclipse proton therapy treatment planning system version 8.9 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Clinical outcomes and patterns of disease recurrence following intensity modulated proton therapy for oropharyngeal squamous carcinoma: results from a single institution prospective study Article Snippet: Article Title: Conventionally fractionated large volume head and neck re-irradiation using multileaf collimator-based robotic technique: A feasibility study Article Snippet: Treatment planning and dose calculation was done on an Article Title: Prospective longitudinal patient-reported outcomes of swallowing following intensity modulated proton therapy for oropharyngeal cancer. Article Snippet: BACKGROUND AND PURPOSE With an enlarging population of long-term oropharyngeal cancer survivors, dysphagia is an increasingly important toxicity following oropharynx cancer treatment.. While lower doses to normal surrounding structures may be achieved with intensity modulated proton therapy (IMPT) compared to photon-based radiation, the clinical benefit is uncertain.. METHODS AND MATERIALS Seventy-one patients with stage III/IV oropharyngeal cancer undergoing definitive IMPT on a longitudinal prospective cohort study who had completed the MD Anderson Dysphagia Inventory (MDADI) at prespecified time points were included. Article Title: Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation: A case-matched control analysis. Article Snippet: A potential advantage of intensity-modulated proton therapy (IMPT) over intensity-modulated (photon) radiation therapy (IMRT) in the treatment of oropharyngeal carcinoma (OPC) is lower radiation dose to several critical structures involved in the development of nausea and vomiting, mucositis, and dysphagia.. The purpose of this study was to quantify doses to critical structures for patients with OPC treated with IMPT and compare those with doses on IMRT plans generated for the same patients and with a matched cohort of patients actually treated with IMRT.. In this study, 25 patients newly diagnosed with OPC were treated with IMPT between 2011 and 2012. Article Title: A Prospective Longitudinal assessment of MRI Signal Intensity Kinetics of Non-Target Muscles in Patients with Advanced Stage Oropharyngeal Cancer in Relationship to Radiotherapy Dose and Post-Treatment Radiation-Associated Dysphagia: Preliminary findings from a Randomized Trial Article Snippet: IMPT cases were planned with an Article Title: Multi-field Optimization Intensity-Modulated Proton Therapy for Head and Neck Tumors – A Translation to Practice Article Snippet: Treatment planning was done on an Article Title: Prognostic impact of leukocyte counts before and during radiotherapy for oropharyngeal cancer Article Snippet: Planning for IMPT was done with an |